Aromatase inhibitors versus tamoxifen in early breast cancer: patient-level meta-analysis of the randomised trials

Aromatase inhibitors versus tamoxifen in early breast cancer: patient-level meta-analysis of the randomised trials. Dowsett, M.; Forbes, J. F.; Bradley, R.; Ingle, J.; Aihara, T.; Bliss, J.; Boccardo, F.; Coates, A.; Coombes, R. C.; Cuzick, J.; Dubsky, P.; Gnant, M.; Kaufmann, M.; Kilburn, L.; Perrone, F.; Rea, D.; Thürlimann, B.; van de Velde, C.; Pan, H.; Peto, R.; Davies, C.; Gray, R.. Lancet. 2015; 1341-52: p.1341-52. doi:10.1016/S0140-6736(15)61074-1 10.1016/S0140-6736(15)61074-1. Epub 2015 Jul 23.

Article